论文部分内容阅读
帝斯曼集团11月6日公布,2013年第三季度EBITDA(税息折旧及摊销前利润)达到3.42亿欧元,相比2012年同期的2.7亿欧元上升27%。虽然宏观经济环境依然充满挑战,帝斯曼仍然取得了27%的增长。对于上述业绩,帝斯曼首席执行官兼董事会主席谢白曼表示:“尽管第三季度末营养业务遭遇了一些困难,但表现继续保持优异。材料科学业务也取得了良好的业绩,利润有所提高。此外,谢白曼表示,帝斯曼依然致力于实现并购项目的完全整合,形成强大的合力,同时也在顺利开展广泛的盈利促进计划,为帝斯曼收益状况的改善做出贡献。帝斯曼相
DSM Group announced on November 6 that Q3 2013 EBITDA (profit before tax, depreciation and amortization) reached 342 million euros, a 27% increase from 270 million euros in the same period of 2012. Although the macroeconomic environment remains challenging, DSM still achieved 27% growth. For the above performance, Xie Bieman, chief executive officer and chairman of the board of DSM, said: ”Despite continuing difficulties in the nutrition business at the end of Q3, the performance continued to be excellent. The materials science business also achieved good results with profit In addition, Xie Bieman said DSM is still committed to achieving the full integration of mergers and acquisitions projects, forming a strong synergy, but also smooth progress in a wide range of profit-making plans to DSM revenue contribution to the improvement of the situation DSM phase